Wockhardt Group Does Not Expect Much Impact From US Tariffs
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU

US Tariffs: Only Sun Pharma Exposed To Some Headline Risk, But With Limited Earnings Impact

Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs


India-US Trade Talks To Resume As Negotiator Arrives In Delhi: Timeline Of Key Events


Wockhardt Eyes ‘Healthy Bottom Line’ In Coming Quarters Amid US Tariff Concerns
